Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study. 2008

Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
Centre for Biotechnology, JNT University, Kukatpally, Hyderabad-500 072, India.

A highly selective, sensitive and accurate HPLC method has been developed and validated for the estimation of three fluoroquinolones (FQs) viz., gatifloxacin (GFC), sparfloxacin (SFC) and moxifloxacin (MFC) with 500 microL human plasma using levofloxacin (LFC) as an internal standard (IS). The sample preparation involved simple liquid-liquid extraction of GFC, SFC, MFC and IS from human plasma with ethyl acetate. The resolution of peaks was achieved with phosphate buffer (pH 2.5)-acetonitrile (80:20, v/v) at a flow rate of 1 mL/min on a Kromasil C(18) column. The total chromatographic run time was 18.0 min and the simultaneous elution of GFC, SFC, MFC and IS occurred at approximately 10.8, 12.8, 17.0 and 6.0 min, respectively. The method proved to be accurate and precise at linearity range of 100-10,000 ng/mL with a correlation coefficient (r) of > or =0.999. The limit of quantitation for each of the FQs studied was 100 ng/mL. The intra- and inter-day precision and accuracy values found to be within the assay variability limits as per the FDA guidelines. The developed assay method was applied to a pharmacokinetic study in human volunteers following oral administration of 400 mg GFC tablet.

UI MeSH Term Description Entries
D008297 Male Males
D011804 Quinolines
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077266 Moxifloxacin A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. 1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid,Actira,Avalox,Avelox,BAY 12-8039,BAY 128039,BAY-12-8039,BAY-128039,Izilox,Moxifloxacin Hydrochloride,Octegra,Proflox,BAY 12 8039,BAY128039
D000077734 Gatifloxacin A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS. 1-cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid,AM 1155,AM-1155,BMS-206584,CG 5501,Gatifloxacine,Tequin,Zymar,BMS 206584,BMS206584
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001372 Aza Compounds Organic chemicals where carbon atoms have been replaced by nitrogen atoms. Compounds, Aza
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
July 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
July 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
November 2015, Biomedical chromatography : BMC,
Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
March 2013, Experimental and therapeutic medicine,
Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
September 2015, Biomedical chromatography : BMC,
Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
November 2012, Biomedical chromatography : BMC,
Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
August 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
January 2012, Scientia pharmaceutica,
Nimmagadda Srinivas, and Lakshmi Narasu, and B Prabha Shankar, and Ramesh Mullangi
August 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Copied contents to your clipboard!